Gilmore Neil O'Neill

CEO at Editas Medicine Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Editas Medicine Inc., 3 years.

Editas Medicine Inc. Director · CEO
3 years · Since 2023

Chief executive roles

Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 11, 2026 Editas Medicine Inc. Open-market sale −21,164 $2.42 $51,122
Nov 5, 2026 Editas Medicine Inc. Grant or award +43,567 — —
Sep 3, 2026 Editas Medicine Inc. Open-market sale −5,124 $3.04 $15,577
Jun 3, 2026 Editas Medicine Inc. Open-market sale −15,380 $2.70 $41,526
Mar 3, 2026 Editas Medicine Inc. Open-market sale −5,394 $2.02 $10,896
Dec 3, 2025 Editas Medicine Inc. Open-market sale −5,603 $2.15 $12,046
Sep 3, 2025 Editas Medicine Inc. Open-market sale −5,592 $2.60 $14,539
Jun 3, 2025 Editas Medicine Inc. Open-market sale −15,192 $1.72 $26,130
Mar 4, 2025 Editas Medicine Inc. Open-market sale −16,632 $1.71 $28,441
Dec 3, 2024 Editas Medicine Inc. Open-market sale −1,618 $2.08 $3,365
Sep 4, 2024 Editas Medicine Inc. Open-market sale −1,555 $3.42 $5,318
Jun 4, 2024 Editas Medicine Inc. Open-market sale −12,191 $5.50 $67,051
Mar 5, 2024 Editas Medicine Inc. Open-market sale −77,824 $9.42 $733,102
Mar 2, 2024 Editas Medicine Inc. Grant or award +130,700 — —
Mar 2, 2024 Editas Medicine Inc. Grant or award +72,213 — —

Questions about Gilmore Neil O'Neill

What boards is Gilmore Neil O'Neill on?

Gilmore Neil O'Neill sits on the board of Editas Medicine Inc.

What company is Gilmore Neil O'Neill the CEO of?

Gilmore Neil O'Neill is CEO of Editas Medicine Inc.

How long has Gilmore Neil O'Neill served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.